This aligns with previous studies showing increased serpins, including AAT, in COVID-19 sera, particularly in patients with high Interleukin-6 levels [36], and evidence suggesting that AAT deficiency increases the risk of severe COVID-19 [37]. This evidence concerns the gene SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4.